You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《亞洲股市》印尼、澳洲及星股反彈1%-1.5% 惟臺港日股逆跌1%-2.2%
美國經濟數據普遍勝預期,加上藍籌藥廠默克(MRK.US)公佈其研發新冠口服藥Molnupiravir能使確診者的住院和死亡率減半,並將向美國等其他國家申請緊急授權使用,美股上週五在經濟敏感及旅遊相關股重現買盤帶動全面反彈0.8%-1.4%,藍籌指數彈力最大。美股期貨全面反覆回落0.3%-0.4%,道指期貨沽壓最小,報34,069,回吐98點。 亞太區股市普遍反彈,尤其是星洲股市回升1.5%報3,096;印尼回升1.4%報6,316;澳洲200反彈1%曾高見7,305。 越南、新西蘭、菲股及泰股回升0.3%-0.7%,分別報1,339、13,329、6,943及1,616;大馬股市反覆回穩報1,525。 然而,日經連跌第六天,今早曾扭轉上週五急挫2.3%勢,反彈275點至29,046無以爲繼,掉頭低見28,359,現報28,417,續跌353點或1.2%。臺灣加權指數繼上週五急吐2.2%後,今早曾回升0.6%至16,680無以爲繼,現報16,412,倒跌近1%。 港股於長週末假後復市在匯控(00005.HK)/建行(00939.HK)/友邦(01299.HK)/招行(03968.HK)/中國平安(02318.HK)跌近2%-4%、美團(03690.HK)和屢尋底阿裏巴巴(09988.HK)挫4%和2.3%,以及藥明生物(02269.HK)急挫7.7%領跌,最低見23,908,半日收24,022,急挫553點或近2.3%。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account